Justicia-Lirio, P., Tristán-Manzano, M., Maldonado-Pérez, N., Barbero-Jiménez, C., Cortijo-Gutiérrez, M., Pavlovic, K., . . . Martín, F. First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas. Elsevier.
Chicago Style (17th ed.) CitationJusticia-Lirio, Pedro, et al. First-in-class Transactivator-free, Doxycycline-inducible IL-18-engineered CAR-T Cells for Relapsed/refractory B Cell Lymphomas. Elsevier.
MLA (9th ed.) CitationJusticia-Lirio, Pedro, et al. First-in-class Transactivator-free, Doxycycline-inducible IL-18-engineered CAR-T Cells for Relapsed/refractory B Cell Lymphomas. Elsevier.
Warning: These citations may not always be 100% accurate.